Skip to content
GLP-1 Desk
Menu

Head-to-head dispatch

HealthRX vs Lttl

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Dispatch #11Desk pick
HealthRX

A LegitScript-certified telehealth desk with a rare oral GLP tablet route alongside injectables and physician-reviewed intake.

Marked down on: Compounded medications are not FDA-approved

vs
Dispatch #159
Lttl

Lttl (pronounced “little”) publishes its entire term ladder on one public page — every medication, route and commitment length, month-to-month rung included — alongside compounded semaglutide and tirzepatide, a low-dose microdose line and a longevity range.

Marked down on: One advertised figure is purchasable at no tier: every product card prints the same “from $129/mo”, including tirzepatide, whose own four rungs are $279, $249, $229 and $199

HealthRX takes this head-to-head with the higher Desk Score, 86/100 (B) against 66/100 (C) for Lttl. Lttl still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

HealthRX

86/100

B

Overall

Lttl

66/100

C

Price transparency

82
78

State access

80
24

Molecule range

94
90

Onboarding speed

84
70

Support responsiveness

82
73

Licensing & trust

90
65

The spec sheet

FieldHealthRXLttl
Semaglutide$190/mo month-to-month ($99 first month, renews at $165) · $99/mo on a 12-month prepay ($1,188)$199/mo month-to-month (compounded injectable; oral ODT $229/mo; the advertised $129/mo is a $1,548 annual prepay)
Tirzepatide$239/mo month-to-month ($149 first month, renews at $214) · $179/mo on a 12-month prepay ($2,148)$279/mo month-to-month (compounded injectable; the $129/mo on its product card matches no tirzepatide tier — the cheapest is $199/mo on a $2,388 annual prepay)
CoverageUnited StatesCoverage not published
Brand-nameYesYes
Oral optionYesYes
Best forPatients who want a certified, physician-supervised program and the option of an oral tablet instead of an injection.Shoppers who want to see every commitment tier priced before they hand over any details, and who want a low-dose microdose option next to the full-strength lines.
Desk Score86/100B66/100C

The verdict

Desk pick — HealthRX

HealthRX takes this head-to-head with the higher Desk Score, 86/100 (B) against 66/100 (C) for Lttl. Lttl still holds its ground where its strengths line up with yours.

Choose HealthRX if…

Patients who want a certified, physician-supervised program and the option of an oral tablet instead of an injection.

$190/mo month-to-month ($99 first month, renews at $165) · $99/mo on a 12-month prepay ($1,188) sema · $239/mo month-to-month ($149 first month, renews at $214) · $179/mo on a 12-month prepay ($2,148) tirz · United States

Choose Lttl if…

Shoppers who want to see every commitment tier priced before they hand over any details, and who want a low-dose microdose option next to the full-strength lines.

$199/mo month-to-month (compounded injectable; oral ODT $229/mo; the advertised $129/mo is a $1,548 annual prepay) sema · $279/mo month-to-month (compounded injectable; the $129/mo on its product card matches no tirzepatide tier — the cheapest is $199/mo on a $2,388 annual prepay) tirz · Coverage not published

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: HealthRX · Lttl.

Also here

CoreAge Rx tops every dispatch at 94/100

Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.